<ѻýҕl>Three-Drug Regimen Reduces Myeloma Treatment Burdenѻýҕl> Efficacy maintained with addition of SQ daratumumab to pomalidomide, dexamethasone Dec 04, 2020
<ѻýҕl>Bone Marrow Improves Healing With ACL Graftsѻýҕl> MRI confirms better outcomes than with allograft alone in randomized study Dec 04, 2020
<ѻýҕl>FDA OKs 'Game Changer' Radiotracer for Prostate Cancerѻýҕl> PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
<ѻýҕl>Study Reassures on MS Patients' Breast, Colorectal Cancer Riskѻýҕl> But higher incidence of other cancers in Canadian data Nov 25, 2020
<ѻýҕl>Potential New Option in Aggressive, Ultra Rare Sarcomaѻýҕl> Highly durable responses with nab-sirolimus in malignant PEComa Nov 21, 2020
<ѻýҕl>Cellular Therapies Promising in Advanced Synovial Sarcomaѻýҕl> Two different strategies yield impressive results in patients with recurrent or metastatic disease Nov 20, 2020
<ѻýҕl>Tiny Lung Micronodules in Bone Sarcoma Not Even a Tiny Problem?ѻýҕl> Five-year survival no worse in patients with micronodules under 5 mm Nov 20, 2020
<ѻýҕl>Lorlatinib Shows 'Striking' CNS Activity in ALK Lung Cancerѻýҕl> But unusual adverse events may hold therapy back Nov 18, 2020
<ѻýҕl>New Clinical Strategy for HR-Positive Breast Cancer?ѻýҕl> Ki67 values before, after preop endocrine therapy associated with recurrence risk Nov 17, 2020
<ѻýҕl>IL-8 Antibody Active in Tumors After PD-1/L1 Blockadeѻýҕl> Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<ѻýҕl>PD-1 Inhibitor Active in Progressive Basal Cell Cancerѻýҕl> Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance Nov 11, 2020
<ѻýҕl>Al Roker's Prostate Cancerѻýҕl> Morning show stalwart's diagnosis highlights discrepancies for Black men Nov 10, 2020
<ѻýҕl>Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapseѻýҕl> Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
<ѻýҕl>IVF Babies With Birth Defects Also Show Increased Cancer Riskѻýҕl> Absolute risk is small, but findings should prompt further research Oct 29, 2020
<ѻýҕl>New-Onset Diabetes and Pancreas Cysts a Risky Mixѻýҕl> Study provides support for assessing diabetes markers in pancreatic cyst surveillance Oct 28, 2020
<ѻýҕl>More Top Research From Kidney Week 2020ѻýҕl> Additional studies on anemia, heart risk, and racial disparities in chronic kidney disease Oct 27, 2020
<ѻýҕl>High-Dose SBRT More Effective for Painful Spine Metastasesѻýҕl> Roughly one-third of patients had a complete pain response at 3 and 6 months Oct 26, 2020
<ѻýҕl>Anal Cancer on the Rise in U.S., Especially in Womenѻýҕl> Whites also had a higher risk than Blacks for HPV-linked disease Oct 26, 2020
<ѻýҕl>FIT Could Accurately Rule Out CRC in Symptomatic Patientsѻýҕl> Outperforms symptoms in sensitivity and equals colonoscopy at 2 µg/g hemoglobin cutoff Oct 22, 2020
<ѻýҕl>Newborns Getting Preoperative Blood Transfusions Have More Complicationsѻýҕl> Data favor restrictive transfusion strategy Oct 22, 2020
<ѻýҕl>COVID-19 Plus Cancer Proves Deadlyѻýҕl> Over a third of cancer patients sent to the ICU died Oct 22, 2020
<ѻýҕl>COVID Deaths Drop in the Hospitalized; Miracle Mouthwash? New Organ Discoveredѻýҕl> A daily roundup of news on COVID-19 and the rest of medicine Oct 21, 2020
<ѻýҕl>CDK4/6 Inhibitor in SCLC Cuts Chemo-Induced Myelosuppressionѻýҕl> Reduced severe neutropenia and less need for supportive care with trilaciclib Oct 20, 2020
<ѻýҕl>Suze Orman's Schwannomaѻýҕl> Financial guru talks about her "most vital and stupid mistake" Oct 19, 2020
<ѻýҕl>Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLCѻýҕl> Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status Oct 17, 2020
<ѻýҕl>COVID Heart Autopsies Point More to Clot Damage Than Myocarditisѻýҕl> Results bolster case for anticoagulation in hospitalized patients Oct 15, 2020
<ѻýҕl>More Evidence Points to Role of Blood Type in COVID-19ѻýҕl> Two studies find ties to infection susceptibility, severity, but with caveats Oct 14, 2020
<ѻýҕl>Surprise Billing Seen Likely for Many Colonoscopiesѻýҕl> And would be illegal for uncomplicated procedures Oct 12, 2020
<ѻýҕl>Look for Bone Mets at Soft Tissue Sarcoma Diagnosisѻýҕl> Lung scan only would have missed 40% of all metastases, majority of bone disease, study finds Oct 12, 2020
<ѻýҕl>Eddie Van Halen's Head and Neck Cancerѻýҕl> A look at what caused the legendary guitarist's death Oct 12, 2020
<ѻýҕl>With H. Pylori, Higher-Dose PPIs May Promote Gastric Intestinal Metaplasiaѻýҕl> Retrospective Israeli study comes with many caveats, however Sep 24, 2020
<ѻýҕl>These Forbes 400 Billionaires Made Their Fortunes in Healthcareѻýҕl> 14 individuals, $66 billion in combined net worth Sep 24, 2020
<ѻýҕl>Positive Anti-PD-1 Data in Gastric, Esophageal Cancerѻýҕl> Better OS, PFS with nivolumab, pembrolizumab in advanced/metastatic disease Sep 23, 2020
<ѻýҕl>Immunotherapy Falls Short Again in Ovarian Cancerѻýҕl> No PFS benefit in advanced disease with addition of atezolizumab to chemo, bevacizumab Sep 23, 2020
<ѻýҕl>Novel Tx Helps Some Advanced Cervical Cancer Patientsѻýҕl> Three-fourths in small trial obtain disease control or better with antibody-drug conjugate Sep 22, 2020
<ѻýҕl>No Luck for Chemo-Free Tx in First-Line Bladder Cancerѻýҕl> Durvalumab alone or with tremelimumab no better than chemotherapy Sep 22, 2020
<ѻýҕl>No Benefit With Anti-PD-L1 Drug in Metastatic TNBCѻýҕl> Lack of progression-free, overall survival boost with atezolizumab contrast with prior trial Sep 22, 2020
<ѻýҕl>Adjuvant Anti-CDK Thwarts Early Breast Cancer Recurrenceѻýҕl> Risk of invasive recurrence declines 25% in patients with high-risk disease Sep 20, 2020
<ѻýҕl>Newly Approved Drug Boosts Survival in Metastatic TNBCѻýҕl> Antibody-drug conjugate as third-line option improved survival, response rates Sep 20, 2020